(Note: This blank-check or SPAC IPO is an offering of Class A ordinary shares and NOT units. The typical blank-check or SPAC IPO consists of units (stock plus warrants to buy stock). Gobi Acquisition Corp. was incorporated in the Cayman Islands.) We intend to seek targets that have an established presence in Asia Pacific, or […]

We intend to capitalize on our management team’s ability and its access to the broader Elliott platform to identify and acquire opportunities in the technology sector that we believe have leading market positions, operate in a space with a large and growing total addressable market (“TAM”), have a track record of sustainable growth with identifiable […]

EverCommerce is a leading provider of software-as-a-service (SaaS) solutions for service-based small- and medium-sized businesses, or service SMBs. Today, we serve over 500,000 customers across three core verticals: Home Services, Health Services and Fitness & Wellness Services. Our customers range from home improvement contractors and home maintenance technicians to physician practices and therapists to personal trainers and […]

Founded in 2000, Hepsiburada is one of the early pioneers of digitalization of commerce in Turkey. It has become a household brand in the country. Our brand, which means “Everything is Here,” is synonymous with a seamless online shopping experience. Hepsiburada scored 96% for aided brand awareness (with the two closest competitors in Turkey scoring […]

(Note: The American Depositary Shares (ADS) in this IPO will be issued by Atour Lifestyle Holdings Limited, the holding company incorporated in the Cayman Islands.) Setting out as an upper midscale hotel chain group, we are now a leading lifestyle brand in China. We are the largest upper midscale hotel chain in China in terms […]

We are a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease, or AD. Alzheimer’s disease is a progressive neurodegenerative disease of the brain that leads to loss of memory and cognitive functions and ultimately results in death. Our scientific founders pioneered […]

Our mission is to accelerate innovation by providing real time, equitable access to global manufacturing capacity and demand. Our vision is to drive efficiency, sustainability and innovation by lowering the barriers to entry to the manufacturing ecosystem. We are a leading AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. We use our proprietary […]

We are a commercial-stage medical device company developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Our proprietary platform technology, BAROSTIM,  leverages the brain’s power to address the imbalance of the Autonomic Nervous System (“ANS”), which causes heart failure (“HF”) and other cardiovascular diseases. Our second-generation product, BAROSTIM NEO, […]

We are a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Our initial focus is on advancing AV-101, our dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, or PAH, a devastating disease impacting approximately 70,000 people in the United […]

We launched CLEAR in 2010 to create a frictionless travel experience while enhancing homeland security.  Following 9/11, there was a dire need for safer and easier experiences in the aviation industry. Biometrics helped solve this requirement. CLEAR’s secure identity platform uses biometrics (e.g., eyes, face and fingerprints) to automate the identity verification process through CLEAR lanes in […]